Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.36 |
| ▸ | TUBB | P07437 | 1/20 | 0.36 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.36 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.36 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.36 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.36 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.36 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.36 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.36 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.36 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.36 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.36 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.36 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.36 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8980364 | 0.98 | SIRT1 (0.39) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL3201612 | 0.96 | SIRT1 (0.40) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL29848318 | 0.93 | SIRT1 (0.36) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL6932181 | 0.89 | — | — | |
| SCHEMBL12570083 | 0.87 | KDM4E (0.34) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| Hydrochloric Acid SCHEMBL8567943 | 0.87 | — | — | |
| SCHEMBL5849458 | 0.85 | MAPT (0.37) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| Trifluoromethanesulfonic Acid SCHEMBL5850147 | 0.83 | PTGS1 (0.39) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL5849481 | 0.81 | TDP1 (0.39) | MAPTKDM4ENSD2MAPK1HPGD | |
| SCHEMBL9625398 | 0.80 | SIRT1 (0.38) | SIRT1MAPTKDM4ENSD2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120044753-B | Photosensitive dry film, photosensitive resin composition, cured film and printed circuit board | Hangzhou foster Electronic Materials Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-110713577-A | Expansion monomer modified light-cured resin and preparation method thereof | 点铂医疗科技（常州）有限公司 | 2020-01-21 | — | — | CN | claimed |
| US-9695272-B2 | Divinylarene dioxide resin compositions | BLUE CUBE IP LLC (US) | 2017-07-04 | — | — | US | claimed |
| US-20160152846-A1 | CURABLE RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC | 2016-06-02 | — | — | US | claimed |
| EP-2585536-B1 | CURABLE RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-04-29 | — | — | EP | claimed |
| EP-2861645-A1 | CURABLE COMPOSITIONS | Dow Global Technologies LLC (US) | 2015-04-22 | — | — | EP | claimed |
| US-20150087749-A1 | CURABLE COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-03-26 | — | — | US | claimed |
| WO-2013188070-A1 | CURABLE COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-12-19 | — | — | WO | claimed |
| EP-2585513-A2 | CURABLE RESIN COMPOSITIONS | Dow Global Technologies LLC (US) | 2013-05-01 | — | — | EP | claimed |
| EP-2585536-A2 | CURABLE RESIN COMPOSITIONS | Dow Global Technologies LLC (US) | 2013-05-01 | — | — | EP | claimed |
| US-20130090407-A1 | CURABLE RESIN COMPOSITIONS | BLUE CUBE IP LLC | 2013-04-11 | — | — | US | claimed |
| WO-2012009118-A2 | CURABLE RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-01-19 | — | — | WO | claimed |
| WO-2012009120-A2 | CURABLE RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-01-19 | — | — | WO | claimed |
| US-20110319515-A1 | DIVINYLARENE DIOXIDE RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-12-29 | — | — | US | claimed |
| EP-4735260-A1 | EPOXY-BASED UV-VIS-CURABLE COMPOSITIONS | Sicpa Holding SA (CH) | 2026-05-06 | — | — | EP | disclosed |
| US-20260092142-A1 | RESIN COMPOSITION, CURED PRODUCT, SCINTILLATOR PANEL, AND INDUCTOR | TORAY INDUSTRIES, INC. (JP) | 2026-04-02 | — | — | US | disclosed |
| US-20260015799-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2026-01-15 | — | — | US | disclosed |
| EP-0344910-A2 | Energy curable compositions: two component curing agents | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-12-06 | — | — | EP | disclosed |
| EP-0306162-A2 | Energy-induced dual curable compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-03-08 | — | — | EP | disclosed |
| EP-0306161-A2 | Energy-induced curable compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-03-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092142-A1 | RESIN COMPOSITION, CURED PRODUCT, SCINTILLATOR PANEL, AND INDUCTOR | PTGER1, RPTOR, LCP1 | SIRT1 1612/4885MAPT 3533/4885KDM4E 556/4885 |
| US-20260015799-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | IK, TEX10, INCENP | SIRT1 2935/4885MAPT 509/4885KDM4E 302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.